Clinical Trials Browser

Interventional × Has announcements × fostamatinib × Clear all

NCT02077192 2023-12-11

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Phase 3 Completed

123 enrolled 11 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT02076399 2019-02-12

FIT

Phase 3 Completed

76 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT02076412 2019-01-25

FIT

Phase 3 Completed

74 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic